Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Shanks

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The American Journal of Tropical Medicine and Hygiene|February 1, 1994
Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in ThailandG Watt, L Loesuttiviboon, K Jongsakul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study GroupG D Shanks, B L Smoak, G M Aleman, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1991
Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infectionsG D Shanks, G Watt, M D Edstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malariaG D Shanks, D M Gordon, F W Klotz, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeysN Obaldia, R N Rossan, R D Cooper, et al.
Epidemiology and Infection|March 10, 2016
Enhanced risk of illness during the 1918 influenza pandemic after previous influenza-like illnesses in three military populationsG D Shanks, S A Burroughs, J D Sohn, et al.
Lancet (London, England)|July 4, 1987
Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasisW R Ballou, J B McClain, D M Gordon, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in ThailandG Watt, L Loesuttivibool, G D Shanks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2001
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malariaG D Shanks, A J Oloo, G M Aleman, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1993
Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulattaK D Corcoran, P Hansukjariya, J Sattabongkot, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Tropical Medicine and Hygiene|February 1, 1994
Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in ThailandG Watt, L Loesuttiviboon, K Jongsakul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study GroupG D Shanks, B L Smoak, G M Aleman, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1991
Halofantrine for the treatment of mefloquine chemoprophylaxis failures in Plasmodium falciparum infectionsG D Shanks, G Watt, M D Edstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malariaG D Shanks, D M Gordon, F W Klotz, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeysN Obaldia, R N Rossan, R D Cooper, et al.
Epidemiology and Infection|March 10, 2016
Enhanced risk of illness during the 1918 influenza pandemic after previous influenza-like illnesses in three military populationsG D Shanks, S A Burroughs, J D Sohn, et al.
Lancet (London, England)|July 4, 1987
Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasisW R Ballou, J B McClain, D M Gordon, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in ThailandG Watt, L Loesuttivibool, G D Shanks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2001
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malariaG D Shanks, A J Oloo, G M Aleman, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1993
Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulattaK D Corcoran, P Hansukjariya, J Sattabongkot, et al.
Pageof 8